Human medicines European public assessment report (EPAR): Libtayo, cemiplimab, Date of authorisation: 28/06/2019, Revision: 22, Status: Authorised | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 20 January 2026 - 16:20

Human medicines European public assessment report (EPAR): Libtayo, cemiplimab, Date of authorisation: 28/06/2019, Revision: 22, Status: Authorised

Link:

https://www.ema.europa.eu/en/medicines/human/EPAR/libtayo

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters